Jw. Kronson et al., POSTTRANSPLANT NONFUNCTION OF CANINE ISLETS IN PVG RATS DEFICIENT IN COMPLEMENT COMPONENT C6, Transplantation, 65(12), 1998, pp. 1549-1554
Background. Discordant islet xenografts are immediately nonfunctional
in nonimmunosuppressed recipients other than the mouse, a process call
ed primary nonfunction, Although at present it is unknown whether comp
lement is involved, complement might participate in the induction of p
rimary nonfunction through a number of mechanisms. We investigated the
potential role of the membrane attack complex of complement in primar
y nonfunction of transplanted xenoislets, Methods. Canine islets were
transplanted into both nonimmunosuppressed and immunosuppressed normoc
omplementemic and C6-deficient (C6D) PVG rats. Cyclosporine, rapamycin
, deoxyspergualin, and myco-phenolate mofetil were used for immunosupp
ression from day -3 to cessation of islet cell function. Serum glucose
was measured at 6 hr after transplant and daily thereafter. Xenograft
tissue sections were obtained at various times after transplant and s
tained for inflammatory cells and insulin. Results. Canine islets graf
ted in nonimmunosuppressed C6D rats and normocomplementemic rats under
went primary nonfunction in all animals. The incidence of primary nonf
unction in animals receiving a four-drug immunosuppressive regimen was
33% in the normocomplementemic rats but only 10% in the C6D rats. The
mean functional islet survival time was 1.57+/-0.33 days in the normo
complementemic group and 2.70+/-0.67 days in the C6D group (P=0.38), T
he islet xenografts showed little difference in degree and composition
of cell infiltration between normocomplementemic and C6D rats. Conclu
sion. The membrane attack complex does not appear to play a major role
in primary nonfunction of canine islet xenografts in nonimmunosuppres
sed PVG rats. However, there was a lower incidence of primary nonfunct
ion and a longer posttransplant survival time in immunosuppressed C6D
rats, suggesting the membrane attack complex may play a minor role in
recipients that are heavily immunosuppressed.